Surgery Type Does Not Impact Breast Cancer Survival in Younger Patients
Lumpectomy appears as effective as mastectomy for younger women with nonmetastatic invasive breast cancer.
Lumpectomy appears as effective as mastectomy for younger women with nonmetastatic invasive breast cancer.
Patient age and tumor site were linked to the risk of local recurrence, and histological response to neoadjuvant chemotherapy was tied to the risk of new metastatic disease.
Researchers compared patients with giant cell tumor of the bone who were treated with surgery alone or surgery plus preoperative denosumab.
A minimally invasive approach does not increase risk for atypical sites of kidney cancer recurrence, a recent study suggests.
The 5-year metastasis-free survival was similar with trimodal therapy and radical cystectomy.
A team from The Ohio State University Cancer Center describes a novel approach to patient care before, during, and after surgery.
Researchers found that entry into the ventricle space during surgical resection elevated the risk of leptomeningeal disease in patients with melanoma brain metastases.
The rate of VTE-related readmission was 1.7% within 180 days of discharge.
Study findings support radical cystectomy as the gold standard therapy for high-risk bladder cancer.
Survival outcomes were better with surgery than with EGFR-TKI treatment alone.